 Valeant Pharmaceuticals International Inc CEO Michael Pearson said the company is nearing its goal of rounding up enough support from Allergan Inc shareholders to secure a vote on its  billion hostile bid for the Botox maker Once Valeant gets the  of Allergan shareholders needed to convene the vote both sides know how this will come out Mr Pearson said in an interview Tuesday adding that he expects Valeants offer to be accepted